Navigation Links
HUYA Bioscience Announces Partnership With Shanghai Zhangjiang Biotech Pharmaceutical Base
Date:3/6/2013

SAN DIEGO, March 6, 2013 /PRNewswire/ -- HUYA Bioscience International announced today a collaborative partnership with Shanghai Zhangjiang Biotech and Pharmaceutical Base Development Co., Ltd. and Shanghai Pharma Engine Co. Ltd. (collectively, "Zhangjiang Biotech Pharmaceutical Base").  HUYA is an international leader in accelerating the global development of China's pharmaceutical innovations.  This new partnership will focus on innovations coming out of companies located in Zhangjiang Biotech Pharmaceutical Base that could meet critical global pharmaceutical pipeline needs.

HUYA is one of the first companies to have recognized China's potential to help meet the global need for new preclinical and clinical stage compounds. The company is committed to facilitating and promoting the global development and commercialization of novel pharmaceutical products originating in China. HUYA has established a series of collaborations with leading universities and research institutes throughout China and has pioneered in-licensing both preclinical and clinical stage compounds from the country, utilizing its expertise to advance these compounds for global markets.

Founded in 1996 and supported jointly by the Ministry of Science and Technology, the Ministry of Health, SFDA, Chinese Academy of Sciences and Shanghai Municipal Government, Zhangjiang Biotech Pharmaceutical Base focuses on the development of innovations in biotechnology and pharmaceutical industries.   As the core district of Shanghai National Bio-Industry Base with the nickname "Zhangjiang Pharmaceutical Valley", after more than 15 years of development it has attracted more than 300 life science companies, research institutes and related service organizations, both domestic and international, and formed a comprehensive bio-pharmaceutical innovation system and industrial clusters.

The partnership will enable HUYA and Zhangjiang Biotech Pharmaceutical Base to collaborate on promoting new drug development worldwide.  Zhangjiang Biotech Pharmaceutical Base will be able to consult with HUYA's team of experts in drug development and globalization.  In turn, HUYA will have the first opportunity to evaluate certain research and development projects conducted at Zhangjiang Biotech Pharmaceutical Base and provide support and assistance as needed.

"HUYA is delighted to work with the prestigious Zhangjiang Biotech Pharmaceutical Base in a partnership that aims to advance the global development of innovative pharmaceutical products from China," said Clement Gingras , HUYA's Chief Technical Officer and COO, China.  "We are very excited about this partnership and look forward to fruitful collaborations in the years to come." 

Senior management of Zhangjiang Biotech Pharmaceutical Base also expressed optimism about this collaboration:  "Our goal is to become a top-rank pharmaceutical development base in Asia, and build a world-renowned biomedical innovation platform.  We hope that HUYA will help accelerate the global reach of innovations originated from 'Zhangjiang Pharmaceutical Valley' by providing expertise on global pharmaceutical development." 

ABOUT HUYA BIOSCIENCE INTERNATIONAL

HUYA is the leader in global pharmaceutical co-development with Chinese partners. With eight offices strategically located across China, the most comprehensive Chinese compound database in the world, and a growing number of collaboration agreements with premier Chinese research and development organizations, HUYA occupies a unique position with regards to the China bio-pharmaceutical industry.  Its strategy to identify and license novel Chinese compounds, and to offer Western pharmaceutical companies efficient and comprehensive access to therapeutic innovation in China, means the company can enable efficient global development.  HUYA has become a champion in guiding China's biomedical innovations into the worldwide marketplace.  HUYA is jointly headquartered in Shanghai and in San Diego, California.  More information is available at www.huyabio.com.

ABOUT ZHANGJIANG BIOTECH PHARMACEUTICAL BASE

Since the establishment of State Biotech and Pharmaceutical Industrial Base (Shanghai) in Zhangjiang in 1996 and implementation of the strategic policy of "Focus on Zhangjiang", Zhangjiang Biotech Pharmaceutical Base has gone through tremendous growth and now houses more than 300 institutions and enterprises, including national research institutes, R&D headquarters of multinational pharmaceutical companies, many domestic pharmaceutical companies, CROs, and public service platforms.  It has become one of the landmark biopharma park and industrial cluster, known for having the highest density of research and development institutions, the highest capability for innovation and the most prominent result for new drug development in China. More information is available at http://www.zjbpb.com/web/index.asp.

Shanghai Pharma Engine Co., Ltd, a wholly owned subsidiary of Zhangjiang Biotech and Pharmaceutical Base Development Co., is a state-level biopharmaceutical incubator, providing technical, contract research and investment consultation services.  More information is available at http://www.zhangjiang.net/tabid/182/ArticleID/462/Default.aspx.

CONTACT

Clement Gingras
CTO and COO, China
HUYA Bioscience International
+1.858.798.8800
cgingras@huyabio.com


'/>"/>
SOURCE HUYA Bioscience International
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Sangamo BioSciences Announces Presentation At The Barclays Global Healthcare Conference
2. Presage Biosciences Announces Strategic Research Alliance with Celgene Corporation
3. Sangamo BioSciences Announces Presentation At 33rd Annual Cowen And Company Health Care Conference
4. Neurocrine Biosciences To Present At The Cowen And Company 33rd Annual Health Care Conference
5. Dr. Mickey Urdea Joins Pressure BioSciences Board of Directors
6. Dr. Susan Froshauer to join Connecticut bioscience team at CURE
7. Sigma-Aldrich Corporations Sigma Life Science Business to Distribute Worldwide Olink Biosciences Protein Interaction Analysis Technology
8. Sangamo BioSciences Reports Fourth Quarter And Full Year 2012 Financial Results
9. Neurocrine Biosciences To Present At The Leerink Swann Global Healthcare Conference 2013
10. Neurocrine Biosciences Announces Conference Call And Webcast To Present Fourth Quarter And Year-End 2012 Financial Results
11. Amarantus BioScience Secures an Additional $1.4 Million in Financing Commitments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/5/2017)... 2017 Kohll,s Pharmacy & Homecare is the first distributor ... States . The Raizer is a simple battery operated ... to an almost-standing position within a few minutes. ... assistant and does not require any extra effort besides ... child can operate it, and lightweight and portable ...
(Date:6/2/2017)... , June 2, 2017  NxStage Medical, Inc. (Nasdaq: ... care, today announced new findings demonstrating positive biochemical outcomes ... System One™. The data will be presented at ... Madrid, Spain . ... Improve Home Dialysis Network in Europe ...
(Date:5/30/2017)... Israel , May 30, 2017 DarioHealth Corp. (NASDAQ: ... big data solutions, today announced that it will be presenting at ... at 8:00 AM PT. Erez Raphael , CEO, of DarioHealth ... The conference will be held on June 6th & 7th, 2017 ... companies in the small / micro-cap space. ...
Breaking Medicine Technology:
(Date:6/23/2017)... ... , ... Ulster University, Magee Campus in Northern Ireland is hosting The Schools ... present to graduate students exciting new and innovative hope research based on iFred’s “Schools ... Health Improvement Service of the Western Health & Social Care Trust (WHSCT) in partnership ...
(Date:6/23/2017)... ... June 23, 2017 , ... All-Star Insurance, a family managed agency that offers ... Texas, is announcing the launch of a new charity drive to benefit women in ... United States reveal that an estimated 252, 710 new cases of invasive or high ...
(Date:6/22/2017)... (PRWEB) , ... June 22, 2017 , ... Branches, Inc. ... more than $245,000 in grant funding to support its programs focused on providing opportunity ... Inc. was awarded a grant by the Foundation of $15,000 to support its , ...
(Date:6/22/2017)... ... June 22, 2017 , ... Groove Ring is excited to announce ... high performance silicon wedding bands and all-purpose rings. Whether you’re an athlete, adventurer, professional, ... designed just for you. , From the rock face to the auto shop, Groove ...
(Date:6/22/2017)... , ... June 22, 2017 , ... ... awards for environmental excellence. Maryland Recycling Network has awarded the Baltimore VA Medical ... Outstanding Small Government Program Award for its efforts to promote waste reduction and ...
Breaking Medicine News(10 mins):